NUS scientists have discovered a novel property of a protein found in human lungs that could lead to the development of biologic drugs to treat chronic obstructive pulmonary disease (COPD), a debilitating, progressive lung ...
Apr 25, 2022
1
164
An experimental medication for critically ill COVID-19 patients appears to work so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization.
Apr 12, 2022
0
9
Multiple prior studies have found higher levels of inflammation in older individuals with depression. Now, a new Penn Medicine study has found that clinically depressed older individuals, on average, don't have elevated levels ...
Mar 29, 2022
0
6
Using their novel organ-on-a-chip platform, a research team from the University of Toronto's Faculty of Applied Science & Engineering has identified a molecule with the potential to combat one of the most severe complications ...
Mar 28, 2022
0
26
In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the "everywhere chemical," to higher incidence of specific childhood cancers.
Mar 16, 2022
0
31
How has the COVID-19 pandemic changed after two years?
Mar 10, 2022
0
9
The American College of Rheumatology (ACR) released two updated guideline papers for the treatment and management of Juvenile Idiopathic Arthritis (JIA). These two guidelines are companions to previously updated JIA guidelines ...
Mar 3, 2022
0
5
A wide-reaching global review has found that some of the most common pain and fever medicines might increase vulnerability to infections like COVID-19, while others may hold hope for improving our immune response.
Mar 1, 2022
0
6
Encephalitis affects nearly 500,000 people of all ages worldwide each year, according to the Encephalitis Society, with young children and older adults most vulnerable. Other risk factors include having a compromised immune ...
Feb 21, 2022
0
14
The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.
Feb 11, 2022
0
13
